Transmission of Surfactant Protein Variants and Haplotypes in Children Hospitalized With Respiratory Syncytial Virus

被引:42
作者
Thomas, Neal J. [1 ,2 ]
Diangelo, Susan [1 ]
Hess, Joseph C. [1 ]
Fan, Ruzong [4 ]
Ball, Margaret W. [5 ]
Geskey, Joseph M. [1 ]
Willson, Douglas F. [5 ]
Floros, Joanna [1 ,3 ]
机构
[1] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA
[2] Penn State Univ, Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA
[3] Penn State Univ, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA
[4] Texas A&M Univ, Dept Stat, College Stn, TX 77843 USA
[5] Univ Virginia, Dept Pediat, Charlottesville, VA 22908 USA
基金
美国国家卫生研究院;
关键词
A GENE LOCUS; ACUTE BRONCHIOLITIS; DISTRESS-SYNDROME; TEST TDT; ASSOCIATION; INFECTION; INFANTS; RISK; DISEQUILIBRIUM; PHAGOCYTOSIS;
D O I
10.1203/PDR.0b013e3181a1d768
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Severity of lung injury with respiratory syncytial virus (RSV) infection is variable and may be related to genetic variations. This preliminary report describes a prospective, family-based association study of children hospitalized secondary to RSV, aimed to determine whether intragenic and other haplotypes of surfactant proteins (SP)-A and SP-D are transmitted disproportionately from parents to offspring with RSV disease. Genomic DNA was genotyped for several SP-A and SP-D single nucleotide polymorphisms (SNPs). Transmission disequilibrium test analysis was used to determine transmission of variants and haplotypes from parents to affected offspring. Three hundred seventy-five individuals were studied, including 148 children with active RSV disease and one or both parents. The SP-A2 intragenic haplotype 1A(2) was found to be protective (p = 0.013). The SP-D SNP DA160_A may possibly be an "at-risk" marker (p = 0.0058). Additional two- and three-marker haplotypes were associated with severe RSV disease with two being protective (DA11+T/DA160_G and DA160_G/SP-A2 1A(0)/SP-A1 6A(2)). We conclude that there may be associations between SP-A and SP-D and RSV disease. Further study is required to determine whether these variants can be used to target a high-risk patient population in clinical trials aimed at reducing either the symptoms of acute infection or long-term pulmonary sequelae. (Pediatr Res 66: 70-73, 2009)
引用
收藏
页码:70 / 73
页数:4
相关论文
共 42 条
[1]   Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database [J].
Arnold, SR ;
Wang, EEL ;
Law, BJ ;
Boucher, FD ;
Stephens, D ;
Robinson, JL ;
Dobson, S ;
Langley, JM ;
McDonald, J ;
MacDonald, NE ;
Mitchell, I .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (10) :866-869
[2]   Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages [J].
Barr, FE ;
Pedigo, H ;
Johnson, TR ;
Shepherd, VL .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2000, 23 (05) :586-592
[3]   Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid [J].
Boyce, TG ;
Mellen, BG ;
Mitchel, EF ;
Wright, PF ;
Griffin, MR .
JOURNAL OF PEDIATRICS, 2000, 137 (06) :865-870
[4]   ACUTE BRONCHIOLITIS - PREDISPOSING FACTORS AND CHARACTERIZATION OF INFANTS AT RISK [J].
CARLSEN, KH ;
LARSEN, S ;
BJERVE, O ;
LEEGAARD, J .
PEDIATRIC PULMONOLOGY, 1987, 3 (03) :153-160
[5]  
CARLSEN KH, 1987, EUR J RESPIR DIS, V70, P86
[6]   Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: A population-based retrospective study [J].
Fjaerli H.-O. ;
Farstad T. ;
Bratlid D. .
BMC Pediatrics, 4 (1)
[7]   Genetics of the hydrophilic surfactant proteins A and D [J].
Floros, J ;
Hoover, RR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1998, 1408 (2-3) :312-322
[8]   Family-based transmission disequilibrium test (TDT) and case-control association studies reveal surfactant protein A (SP-A) susceptibility alleles for respiratory distress syndrome (RDS) and possible race differences [J].
Floros, J ;
Fan, R ;
Matthews, A ;
DiAngelo, S ;
Luo, J ;
Nielsen, H ;
Dunn, M ;
Gewolb, IH ;
Koppe, J ;
van Sonderen, L ;
Farri-Kostopoulos, L ;
Tzaki, M ;
Rämet, M ;
Merrill, J .
CLINICAL GENETICS, 2001, 60 (03) :178-187
[9]  
Floros J., 1997, Anaesthesia: Biologic Foundations, P1257
[10]  
Geskey JM, 2007, BIOL-TARGETS THER, V1, P33